Prostate MRI PI-RADS results: what scores 1 to 5 mean
After a raised PSA, an MRI of the prostate is often used to look for areas that could be a significant cancer. Each area gets a PI-RADS score from 1 (very low chance) to 5 (very high chance). The score is not a diagnosis; only a biopsy can show cancer, and your doctor decides the next step with you. (ACR PI-RADS v2.1) (AUA/SUO, 2023)
What the MRI is for
Prostate MRI uses a magnetic field and radio waves, not radiation, to make detailed pictures of the prostate. (RadiologyInfo, 2026) After a raised PSA, it helps find areas that may be a clinically significant cancer and can guide a targeted biopsy. The AUA/SUO says MRI finds more significant cancers and fewer harmless ones than biopsy alone. (AUA/SUO, 2023) MRI cannot always tell cancer from inflammation or from blood left by a recent biopsy. (RadiologyInfo, 2026)
"Clinically significant" cancer is the kind more likely to need treatment. PI-RADS defines it on biopsy as Gleason score 3+4 or higher, a volume over 0.5 cc, or growth outside the prostate. (ACR PI-RADS v2.1)
PI-RADS scores 1 to 5
The score is based on the MRI only. It does not take in your PSA, a rectal exam or your history. (ACR PI-RADS v2.1) The last two columns show how often studies found a clinically significant cancer (Grade Group 2 or higher) on biopsy; the numbers vary by center and by who is scanned. (AUA/SUO, 2023) (EAU, 2026)
| PI-RADS | What it means (ACR) | Pooled studies (AUA/SUO 2023) | PI-RADS v2.1 studies (EAU 2026) |
|---|---|---|---|
| 1 | Very low: significant cancer highly unlikely | 7% (1 or 2) | 6% |
| 2 | Low: significant cancer unlikely | 6% | |
| 3 | Intermediate: equivocal | 11% | 20% |
| 4 | High: significant cancer likely | 37% | 55% |
| 5 | Very high: significant cancer highly likely | 70% | 83% |
Sources: category wording (ACR PI-RADS v2.1); AUA/SUO table 1, pooled from 23 studies using PI-RADS versions 1.0 to 2.1 (AUA/SUO, 2023); EAU, from a meta-analysis of PI-RADS v2.1. (EAU, 2026)
Why a low score is not a clean bill and a high score is not a diagnosis
- Low (1 or 2): the AUA/SUO says a negative MRI missed a significant cancer in about 1 in 10 people who had not had a biopsy before, with wide variation by study and personal risk. (AUA/SUO, 2023) NICE puts it at 11 to 28 in 100 people with a low-risk MRI. (NICE NG131)
- High (4 or 5): a significant cancer is likely, but some people with these scores have no significant cancer on biopsy (see the table). Only a biopsy can diagnose cancer. (ACR PI-RADS v2.1) (AUA/SUO, 2023)
- A biopsy can find harmless cancer too: NICE says 18 to 23 in 100 people with a low-risk MRI who have a biopsy are diagnosed with a cancer that is unlikely to be life-threatening. (NICE NG131)
PSA density
PSA density is your PSA level divided by your prostate volume, which the MRI report can give. (ACR PI-RADS v2.1) The higher it is, the more likely a significant cancer. The EAU says PSA density and the PI-RADS score each predict significant cancer, and uses them together: in one meta-analysis, the chance with a PI-RADS 1 to 2 MRI ranged from 3% when PSA density was below 0.10 ng/mL/cc to 18% when it was above 0.20. (EAU, 2026) The AUA/SUO lists a PSA density above 0.15 as one factor that can point to a significant cancer after a negative biopsy and MRI. (AUA/SUO, 2023) More on PSA numbers: PSA test results.
When a biopsy is usually discussed
PI-RADS itself says a biopsy should be considered at 4 or 5 but not at 1 or 2, and at 3 it depends on factors beyond the MRI. It leaves the decision to your care team. (ACR PI-RADS v2.1) The guidelines then differ:
| Guideline | MRI before a first biopsy | Low or unclear MRI |
|---|---|---|
| AUA/SUO (US) | May be used (conditional); reasonable, but not yet the standard approach in the 2023 text | People at higher risk with a negative MRI should still have a systematic biopsy; skipping it is a shared decision |
| EAU (Europe) | Recommended (strong) | PI-RADS 1 to 2 with PSA density below 0.20 and no family history: skip biopsy and keep checking PSA. PI-RADS 3 with PSA density below 0.10 and no family history: the same; otherwise consider a targeted biopsy |
| NICE (England) | First test for suspected localized cancer, reported on a 5-point Likert scale | Score 3 or more: offer an MRI-guided biopsy. Score 1 or 2: biopsy may be skipped, but only after talking through risks and benefits together |
Sources: (AUA/SUO, 2023) (EAU, 2026) (NICE NG131) NICE uses a Likert scale, which is also scored 1 to 5 but is not the same system as PI-RADS. (NICE NG131) In 2026 the AUA/SUO updated its guideline and revised the strength of evidence for MRI in people who have not had a biopsy. (AUA/SUO, 2026) Ask your doctor which approach your clinic follows and how your own risk factors change it.
Questions people ask
What does PI-RADS 3 mean?
Intermediate: the radiologist cannot tell from the MRI whether a clinically significant cancer is there. PI-RADS itself says a biopsy may or may not be appropriate at 3, depending on factors other than the MRI, such as PSA density and family history. Your doctor decides with you. (ACR PI-RADS v2.1) (EAU, 2026)
Does PI-RADS 1 or 2 mean I do not have prostate cancer?
No. It means clinically significant cancer is unlikely. The AUA/SUO says about 1 in 10 people with a negative MRI (PI-RADS 1 to 2) who had not had a biopsy before still had a significant cancer on biopsy, and NICE gives 11 to 28 in 100 for a low-risk MRI. (AUA/SUO, 2023) (NICE NG131)
Does PI-RADS 5 mean I have cancer?
Not for certain. A score of 5 means clinically significant cancer is highly likely, but only a biopsy can diagnose cancer. In pooled studies cited by the AUA/SUO, about 70% of people with PI-RADS 5 had a clinically significant cancer. (ACR PI-RADS v2.1) (AUA/SUO, 2023)
What is PSA density?
Your PSA level divided by the size (volume) of your prostate, which the MRI can measure. The higher it is, the more likely a significant cancer is present. European guidelines use it together with the PI-RADS score. (ACR PI-RADS v2.1) (EAU, 2026)
Does my PSA level change the PI-RADS score?
No. PI-RADS is based on the MRI images only and does not include PSA, a rectal exam or your history. Those are weighed separately when deciding on next steps. (ACR PI-RADS v2.1)